Advertisement

Index by Author

April 1999; 22 (4)
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. Adler, A I

    • The diabetes prevention program. Diabetes Care April 1999 22:543-545; doi:10.2337/diacare.22.4.543

  2. Altura, B M

    • Effect of moderate improvement in metabolic control on magnesium and lipid concentrations in patients with type 1 diabetes. Diabetes Care April 1999 22:546-554; doi:10.2337/diacare.22.4.546

  3. Altura, B T

    • Effect of moderate improvement in metabolic control on magnesium and lipid concentrations in patients with type 1 diabetes. Diabetes Care April 1999 22:546-554; doi:10.2337/diacare.22.4.546

  4. Anhalt, H

    • Significant improvement in HbA1c in a morbidly obese type 2 diabetic patient after gastric bypass surgery despite relatively small weight loss. Diabetes Care April 1999 22:651; doi:10.2337/diacare.22.4.651

  5. Aquilino, C

    • Impact of the work environment on glycemic control and adaptation to diabetes. Diabetes Care April 1999 22:569-574; doi:10.2337/diacare.22.4.569

  6. Atsumi, Y

    • T-cell insulitis found in anti-GAD65+ diabetes with residual beta-cell function. A case report. Diabetes Care April 1999 22:615-617; doi:10.2337/diacare.22.4.615

B

  1. Baek, H S

    • Marked weight loss in a type 2 diabetic patient treated with acarbose. Diabetes Care April 1999 22:645-646; doi:10.2337/diacare.22.4.645

  2. Baker, L

    • Cotherapy with recombinant human insulin-like growth factor I and insulin improves glycemic control in type 1 diabetes. RhIGF-I in IDDM Study Group. Diabetes Care April 1999 22:585-592; doi:10.2337/diacare.22.4.585

  3. Beck-Nielsen, H

    • Effect of moderate improvement in metabolic control on magnesium and lipid concentrations in patients with type 1 diabetes. Diabetes Care April 1999 22:546-554; doi:10.2337/diacare.22.4.546

  4. Binder, C

    • Intact proinsulin and beta-cell function in lean and obese subjects with and without type 2 diabetes. Diabetes Care April 1999 22:609-614; doi:10.2337/diacare.22.4.609

  5. Blaabjerg, O

    • Effect of moderate improvement in metabolic control on magnesium and lipid concentrations in patients with type 1 diabetes. Diabetes Care April 1999 22:546-554; doi:10.2337/diacare.22.4.546

  6. Bloomgarden, Z T

    • American Diabetes Association Annual Meeting, 1998. Nephropathy and retinopathy. Diabetes Care April 1999 22:640-644; doi:10.2337/diacare.22.4.640

  7. Bornmyr, S

    • Detection of autonomic sympathetic dysfunction in diabetic patients. A study using laser Doppler imaging. Diabetes Care April 1999 22:593-597; doi:10.2337/diacare.22.4.593

  8. Bouhanick, B

    • Relationship between glomerular hyperfiltration and ACE insertion/deletion polymorphism in type 1 diabetic children and adolescents. Diabetes Care April 1999 22:618-622; doi:10.2337/diacare.22.4.618

  9. Boux de Casson, F

    • Relationship between glomerular hyperfiltration and ACE insertion/deletion polymorphism in type 1 diabetic children and adolescents. Diabetes Care April 1999 22:618-622; doi:10.2337/diacare.22.4.618

  10. Bruno, A

    • Concordance between American Diabetes Association and World Health Organization criteria in a northwestern Italian population. Diabetes Care April 1999 22:652-653; doi:10.2337/diacare.22.4.652

C

  1. Campos, R V

    • Effectiveness of human ultralente versus NPH insulin in providing basal insulin replacement for an insulin lispro multiple daily injection regimen. A double-blind randomized prospective trial. The Canadian Lispro Study Group. Diabetes Care April 1999 22:603-608; doi:10.2337/diacare.22.4.603

  2. Caputo, S

    • Blunted erythropoietin response to anemia in type 1 diabetic patients. Diabetes Care April 1999 22:647; doi:10.2337/diacare.22.4.647b

  3. Castenfors, J

    • Detection of autonomic sympathetic dysfunction in diabetic patients. A study using laser Doppler imaging. Diabetes Care April 1999 22:593-597; doi:10.2337/diacare.22.4.593

  4. Chin, D

    • Significant improvement in HbA1c in a morbidly obese type 2 diabetic patient after gastric bypass surgery despite relatively small weight loss. Diabetes Care April 1999 22:651; doi:10.2337/diacare.22.4.651

  5. Clarke, W L

    • Biopsychobehavioral model of risk of severe hypoglycemia. Self-management behaviors. Diabetes Care April 1999 22:580-584; doi:10.2337/diacare.22.4.580

  6. Compton, P G

    • Cotherapy with recombinant human insulin-like growth factor I and insulin improves glycemic control in type 1 diabetes. RhIGF-I in IDDM Study Group. Diabetes Care April 1999 22:585-592; doi:10.2337/diacare.22.4.585

  7. Cotroneo, P

    • Blunted erythropoietin response to anemia in type 1 diabetic patients. Diabetes Care April 1999 22:647; doi:10.2337/diacare.22.4.647b

  8. Cox, D J

    • Biopsychobehavioral model of risk of severe hypoglycemia. Self-management behaviors. Diabetes Care April 1999 22:580-584; doi:10.2337/diacare.22.4.580

  9. Cundy, T

    • Screening for gestational diabetes. Diabetes Care April 1999 22:653-654; doi:10.2337/diacare.22.4.653

D

  1. D'Agostino, R, Jr

    • Insulin sensitivity in subjects with type 2 diabetes. Relationship to cardiovascular risk factors: the Insulin Resistance Atherosclerosis Study. Diabetes Care April 1999 22:562-568; doi:10.2337/diacare.22.4.562

  2. Damiani, P

    • Blunted erythropoietin response to anemia in type 1 diabetic patients. Diabetes Care April 1999 22:647; doi:10.2337/diacare.22.4.647b

  3. de Boer, M J

    • Primary angioplasty compared with thrombolysis in acute myocardial infarction in diabetic patients. Diabetes Care April 1999 22:647-649; doi:10.2337/diacare.22.4.647a

  4. Dinesen, B

    • Intact proinsulin and beta-cell function in lean and obese subjects with and without type 2 diabetes. Diabetes Care April 1999 22:609-614; doi:10.2337/diacare.22.4.609

  5. Djurhuus, M S

    • Effect of moderate improvement in metabolic control on magnesium and lipid concentrations in patients with type 1 diabetes. Diabetes Care April 1999 22:546-554; doi:10.2337/diacare.22.4.546

F

  1. Fornengo, P

    • Concordance between American Diabetes Association and World Health Organization criteria in a northwestern Italian population. Diabetes Care April 1999 22:652-653; doi:10.2337/diacare.22.4.652

  2. Funae, O

    • T-cell insulitis found in anti-GAD65+ diabetes with residual beta-cell function. A case report. Diabetes Care April 1999 22:615-617; doi:10.2337/diacare.22.4.615

G

  1. Gallois, Y

    • Relationship between glomerular hyperfiltration and ACE insertion/deletion polymorphism in type 1 diabetic children and adolescents. Diabetes Care April 1999 22:618-622; doi:10.2337/diacare.22.4.618

  2. Ghirlanda, G

    • Blunted erythropoietin response to anemia in type 1 diabetic patients. Diabetes Care April 1999 22:647; doi:10.2337/diacare.22.4.647b

  3. Gonder-Frederick, L

    • Biopsychobehavioral model of risk of severe hypoglycemia. Self-management behaviors. Diabetes Care April 1999 22:580-584; doi:10.2337/diacare.22.4.580

  4. Grassi, G

    • Concordance between American Diabetes Association and World Health Organization criteria in a northwestern Italian population. Diabetes Care April 1999 22:652-653; doi:10.2337/diacare.22.4.652

H

  1. Hadjadj, S

    • Relationship between glomerular hyperfiltration and ACE insertion/deletion polymorphism in type 1 diabetic children and adolescents. Diabetes Care April 1999 22:618-622; doi:10.2337/diacare.22.4.618

  2. Haffner, S M

    • Insulin sensitivity in subjects with type 2 diabetes. Relationship to cardiovascular risk factors: the Insulin Resistance Atherosclerosis Study. Diabetes Care April 1999 22:562-568; doi:10.2337/diacare.22.4.562

  3. Hartling, S G

    • Intact proinsulin and beta-cell function in lean and obese subjects with and without type 2 diabetes. Diabetes Care April 1999 22:609-614; doi:10.2337/diacare.22.4.609

  4. Heng, L F

    • Possible sources of discrepancies in the use of the Semmes-Weinstein monofilament. Impact on prevalence of insensate foot and workload requirements. Diabetes Care April 1999 22:598-602; doi:10.2337/diacare.22.4.598

  5. Henriksen, J E

    • Effect of moderate improvement in metabolic control on magnesium and lipid concentrations in patients with type 1 diabetes. Diabetes Care April 1999 22:546-554; doi:10.2337/diacare.22.4.546

  6. Hoorntje, J C

    • Primary angioplasty compared with thrombolysis in acute myocardial infarction in diabetic patients. Diabetes Care April 1999 22:647-649; doi:10.2337/diacare.22.4.647a

  7. Houssa, P

    • Intact proinsulin and beta-cell function in lean and obese subjects with and without type 2 diabetes. Diabetes Care April 1999 22:609-614; doi:10.2337/diacare.22.4.609

  8. Howard, B

    • Insulin sensitivity in subjects with type 2 diabetes. Relationship to cardiovascular risk factors: the Insulin Resistance Atherosclerosis Study. Diabetes Care April 1999 22:562-568; doi:10.2337/diacare.22.4.562

I

  1. Imazu, Y

    • T-cell insulitis found in anti-GAD65+ diabetes with residual beta-cell function. A case report. Diabetes Care April 1999 22:615-617; doi:10.2337/diacare.22.4.615

J

  1. Jones, J A

    • Effects of regular walking on cardiovascular risk factors and body composition in normoglycemic women and women with type 2 diabetes. Diabetes Care April 1999 22:555-561; doi:10.2337/diacare.22.4.555

  2. Julian, D

    • Biopsychobehavioral model of risk of severe hypoglycemia. Self-management behaviors. Diabetes Care April 1999 22:580-584; doi:10.2337/diacare.22.4.580

K

  1. Kangas, T

    • Glycemic control in patients with diabetes in Finland. Diabetes Care April 1999 22:575-579; doi:10.2337/diacare.22.4.575

  2. Kasuga, A

    • T-cell insulitis found in anti-GAD65+ diabetes with residual beta-cell function. A case report. Diabetes Care April 1999 22:615-617; doi:10.2337/diacare.22.4.615

  3. Kawasaki, E

    • Insulitis in an autoimmune-mediated patient originally classified as having type 2 diabetes. Diabetes Care April 1999 22:541-542; doi:10.2337/diacare.22.4.541

  4. Khan, N

    • Significant improvement in HbA1c in a morbidly obese type 2 diabetic patient after gastric bypass surgery despite relatively small weight loss. Diabetes Care April 1999 22:651; doi:10.2337/diacare.22.4.651

  5. Khateeb, N I

    • Significant improvement in HbA1c in a morbidly obese type 2 diabetic patient after gastric bypass surgery despite relatively small weight loss. Diabetes Care April 1999 22:651; doi:10.2337/diacare.22.4.651

  6. Klitgaard, N A

    • Effect of moderate improvement in metabolic control on magnesium and lipid concentrations in patients with type 1 diabetes. Diabetes Care April 1999 22:546-554; doi:10.2337/diacare.22.4.546

  7. Koivisto, V A

    • Glycemic control in patients with diabetes in Finland. Diabetes Care April 1999 22:575-579; doi:10.2337/diacare.22.4.575

  8. Kovatchev, B

    • Biopsychobehavioral model of risk of severe hypoglycemia. Self-management behaviors. Diabetes Care April 1999 22:580-584; doi:10.2337/diacare.22.4.580

  9. Kuntze, J E

    • Cotherapy with recombinant human insulin-like growth factor I and insulin improves glycemic control in type 1 diabetes. RhIGF-I in IDDM Study Group. Diabetes Care April 1999 22:585-592; doi:10.2337/diacare.22.4.585

L

  1. Limal, J M

    • Relationship between glomerular hyperfiltration and ACE insertion/deletion polymorphism in type 1 diabetic children and adolescents. Diabetes Care April 1999 22:618-622; doi:10.2337/diacare.22.4.618

  2. Liu, L

    • RAGE Gly82Ser polymorphism in diabetic microangiopathy. Diabetes Care April 1999 22:646; doi:10.2337/diacare.22.4.646

  3. Lutfey, K E

    • Beyond "compliance" is "adherence". Improving the prospect of diabetes care. Diabetes Care April 1999 22:635-639; doi:10.2337/diacare.22.4.635

  4. Luzio, S D

    • Underdiagnosis of type 2 diabetes by use of American Diabetes Association criteria. Diabetes Care April 1999 22:649-650; doi:10.2337/diacare.22.4.649

M

  1. Manto, A

    • Blunted erythropoietin response to anemia in type 1 diabetic patients. Diabetes Care April 1999 22:647; doi:10.2337/diacare.22.4.647b

  2. Marre, M

    • Relationship between glomerular hyperfiltration and ACE insertion/deletion polymorphism in type 1 diabetic children and adolescents. Diabetes Care April 1999 22:618-622; doi:10.2337/diacare.22.4.618

  3. Martha, P M, Jr

    • Cotherapy with recombinant human insulin-like growth factor I and insulin improves glycemic control in type 1 diabetes. RhIGF-I in IDDM Study Group. Diabetes Care April 1999 22:585-592; doi:10.2337/diacare.22.4.585

  4. Matsuoka, K

    • T-cell insulitis found in anti-GAD65+ diabetes with residual beta-cell function. A case report. Diabetes Care April 1999 22:615-617; doi:10.2337/diacare.22.4.615

  5. McGill, M

    • Possible sources of discrepancies in the use of the Semmes-Weinstein monofilament. Impact on prevalence of insensate foot and workload requirements. Diabetes Care April 1999 22:598-602; doi:10.2337/diacare.22.4.598

  6. Molyneaux, L

    • Possible sources of discrepancies in the use of the Semmes-Weinstein monofilament. Impact on prevalence of insensate foot and workload requirements. Diabetes Care April 1999 22:598-602; doi:10.2337/diacare.22.4.598

  7. Morinaga, S

    • T-cell insulitis found in anti-GAD65+ diabetes with residual beta-cell function. A case report. Diabetes Care April 1999 22:615-617; doi:10.2337/diacare.22.4.615

  8. Mykkänen, L

    • Insulin sensitivity in subjects with type 2 diabetes. Relationship to cardiovascular risk factors: the Insulin Resistance Atherosclerosis Study. Diabetes Care April 1999 22:562-568; doi:10.2337/diacare.22.4.562

N

  1. Nagataki, S

    • Insulitis in an autoimmune-mediated patient originally classified as having type 2 diabetes. Diabetes Care April 1999 22:541-542; doi:10.2337/diacare.22.4.541

O

  1. O'Dea, K

    • Effects of regular walking on cardiovascular risk factors and body composition in normoglycemic women and women with type 2 diabetes. Diabetes Care April 1999 22:555-561; doi:10.2337/diacare.22.4.555

  2. Ollerton, R L

    • Underdiagnosis of type 2 diabetes by use of American Diabetes Association criteria. Diabetes Care April 1999 22:649-650; doi:10.2337/diacare.22.4.649

  3. Ottervanger, J P

    • Primary angioplasty compared with thrombolysis in acute myocardial infarction in diabetic patients. Diabetes Care April 1999 22:647-649; doi:10.2337/diacare.22.4.647a

  4. Owens, D R

    • Underdiagnosis of type 2 diabetes by use of American Diabetes Association criteria. Diabetes Care April 1999 22:649-650; doi:10.2337/diacare.22.4.649

P

  1. Pagano, G

    • Concordance between American Diabetes Association and World Health Organization criteria in a northwestern Italian population. Diabetes Care April 1999 22:652-653; doi:10.2337/diacare.22.4.652

  2. Paradies, K

    • Impact of the work environment on glycemic control and adaptation to diabetes. Diabetes Care April 1999 22:569-574; doi:10.2337/diacare.22.4.569

  3. Park, T S

    • Marked weight loss in a type 2 diabetic patient treated with acarbose. Diabetes Care April 1999 22:645-646; doi:10.2337/diacare.22.4.645

  4. Piers, L S

    • Effects of regular walking on cardiovascular risk factors and body composition in normoglycemic women and women with type 2 diabetes. Diabetes Care April 1999 22:555-561; doi:10.2337/diacare.22.4.555

  5. Pitocco, D

    • Blunted erythropoietin response to anemia in type 1 diabetic patients. Diabetes Care April 1999 22:647; doi:10.2337/diacare.22.4.647b

  6. Playle, R

    • Underdiagnosis of type 2 diabetes by use of American Diabetes Association criteria. Diabetes Care April 1999 22:649-650; doi:10.2337/diacare.22.4.649

  7. Putt, R S

    • Effects of regular walking on cardiovascular risk factors and body composition in normoglycemic women and women with type 2 diabetes. Diabetes Care April 1999 22:555-561; doi:10.2337/diacare.22.4.555

Q

  1. Quattrin, T

    • Cotherapy with recombinant human insulin-like growth factor I and insulin improves glycemic control in type 1 diabetes. RhIGF-I in IDDM Study Group. Diabetes Care April 1999 22:585-592; doi:10.2337/diacare.22.4.585

R

  1. Reunanen, A

    • Glycemic control in patients with diabetes in Finland. Diabetes Care April 1999 22:575-579; doi:10.2337/diacare.22.4.575

  2. Rewers, M

    • Insulin sensitivity in subjects with type 2 diabetes. Relationship to cardiovascular risk factors: the Insulin Resistance Atherosclerosis Study. Diabetes Care April 1999 22:562-568; doi:10.2337/diacare.22.4.562

  3. Ricerca, B M

    • Blunted erythropoietin response to anemia in type 1 diabetic patients. Diabetes Care April 1999 22:647; doi:10.2337/diacare.22.4.647b

  4. Rissanen, A

    • Glycemic control in patients with diabetes in Finland. Diabetes Care April 1999 22:575-579; doi:10.2337/diacare.22.4.575

  5. Roslin, M S

    • Significant improvement in HbA1c in a morbidly obese type 2 diabetic patient after gastric bypass surgery despite relatively small weight loss. Diabetes Care April 1999 22:651; doi:10.2337/diacare.22.4.651

  6. Ross, S

    • Effectiveness of human ultralente versus NPH insulin in providing basal insulin replacement for an insulin lispro multiple daily injection regimen. A double-blind randomized prospective trial. The Canadian Lispro Study Group. Diabetes Care April 1999 22:603-608; doi:10.2337/diacare.22.4.603

  7. Røder, M E

    • Intact proinsulin and beta-cell function in lean and obese subjects with and without type 2 diabetes. Diabetes Care April 1999 22:609-614; doi:10.2337/diacare.22.4.609

S

  1. Saad, M F

    • Insulin sensitivity in subjects with type 2 diabetes. Relationship to cardiovascular risk factors: the Insulin Resistance Atherosclerosis Study. Diabetes Care April 1999 22:562-568; doi:10.2337/diacare.22.4.562

  2. Savage, P J

    • Insulin sensitivity in subjects with type 2 diabetes. Relationship to cardiovascular risk factors: the Insulin Resistance Atherosclerosis Study. Diabetes Care April 1999 22:562-568; doi:10.2337/diacare.22.4.562

  3. Schranz, A G

    • Burden of diabetes in Malta, 1996-2020. Diabetes Care April 1999 22:650; doi:10.2337/diacare.22.4.650

  4. Selby, J

    • Insulin sensitivity in subjects with type 2 diabetes. Relationship to cardiovascular risk factors: the Insulin Resistance Atherosclerosis Study. Diabetes Care April 1999 22:562-568; doi:10.2337/diacare.22.4.562

  5. Shimada, A

    • T-cell insulitis found in anti-GAD65+ diabetes with residual beta-cell function. A case report. Diabetes Care April 1999 22:615-617; doi:10.2337/diacare.22.4.615

  6. Sodoyez-Goffaux, F

    • Intact proinsulin and beta-cell function in lean and obese subjects with and without type 2 diabetes. Diabetes Care April 1999 22:609-614; doi:10.2337/diacare.22.4.609

  7. Spencer, R

    • Possible sources of discrepancies in the use of the Semmes-Weinstein monofilament. Impact on prevalence of insensate foot and workload requirements. Diabetes Care April 1999 22:598-602; doi:10.2337/diacare.22.4.598

  8. Storti, S

    • Blunted erythropoietin response to anemia in type 1 diabetic patients. Diabetes Care April 1999 22:647; doi:10.2337/diacare.22.4.647b

  9. Strack, T

    • Effectiveness of human ultralente versus NPH insulin in providing basal insulin replacement for an insulin lispro multiple daily injection regimen. A double-blind randomized prospective trial. The Canadian Lispro Study Group. Diabetes Care April 1999 22:603-608; doi:10.2337/diacare.22.4.603

  10. Sundkvist, G

    • Detection of autonomic sympathetic dysfunction in diabetic patients. A study using laser Doppler imaging. Diabetes Care April 1999 22:593-597; doi:10.2337/diacare.22.4.593

  11. Suryapranata, H

    • Primary angioplasty compared with thrombolysis in acute myocardial infarction in diabetic patients. Diabetes Care April 1999 22:647-649; doi:10.2337/diacare.22.4.647a

  12. Svensson, H

    • Detection of autonomic sympathetic dysfunction in diabetic patients. A study using laser Doppler imaging. Diabetes Care April 1999 22:593-597; doi:10.2337/diacare.22.4.593

T

  1. Thomas, K

    • Primary angioplasty compared with thrombolysis in acute myocardial infarction in diabetic patients. Diabetes Care April 1999 22:647-649; doi:10.2337/diacare.22.4.647a

  2. Thrailkill, K M

    • Cotherapy with recombinant human insulin-like growth factor I and insulin improves glycemic control in type 1 diabetes. RhIGF-I in IDDM Study Group. Diabetes Care April 1999 22:585-592; doi:10.2337/diacare.22.4.585

  3. Thye-Rønn, P

    • Effect of moderate improvement in metabolic control on magnesium and lipid concentrations in patients with type 1 diabetes. Diabetes Care April 1999 22:546-554; doi:10.2337/diacare.22.4.546

  4. Todaro, L

    • Blunted erythropoietin response to anemia in type 1 diabetic patients. Diabetes Care April 1999 22:647; doi:10.2337/diacare.22.4.647b

  5. Tracy, R

    • Insulin sensitivity in subjects with type 2 diabetes. Relationship to cardiovascular risk factors: the Insulin Resistance Atherosclerosis Study. Diabetes Care April 1999 22:562-568; doi:10.2337/diacare.22.4.562

  6. Trief, P M

    • Impact of the work environment on glycemic control and adaptation to diabetes. Diabetes Care April 1999 22:569-574; doi:10.2337/diacare.22.4.569

  7. Turner, R C

    • The diabetes prevention program. Diabetes Care April 1999 22:543-545; doi:10.2337/diacare.22.4.543

V

  1. Valle, T

    • Glycemic control in patients with diabetes in Finland. Diabetes Care April 1999 22:575-579; doi:10.2337/diacare.22.4.575

  2. Vestergaard, H

    • Intact proinsulin and beta-cell function in lean and obese subjects with and without type 2 diabetes. Diabetes Care April 1999 22:609-614; doi:10.2337/diacare.22.4.609

  3. Vineis, P

    • Concordance between American Diabetes Association and World Health Organization criteria in a northwestern Italian population. Diabetes Care April 1999 22:652-653; doi:10.2337/diacare.22.4.652

W

  1. Walker, K Z

    • Effects of regular walking on cardiovascular risk factors and body composition in normoglycemic women and women with type 2 diabetes. Diabetes Care April 1999 22:555-561; doi:10.2337/diacare.22.4.555

  2. Weinstock, R S

    • Impact of the work environment on glycemic control and adaptation to diabetes. Diabetes Care April 1999 22:569-574; doi:10.2337/diacare.22.4.569

  3. Wishner, W J

    • Beyond "compliance" is "adherence". Improving the prospect of diabetes care. Diabetes Care April 1999 22:635-639; doi:10.2337/diacare.22.4.635

  4. Wollmer, P

    • Detection of autonomic sympathetic dysfunction in diabetic patients. A study using laser Doppler imaging. Diabetes Care April 1999 22:593-597; doi:10.2337/diacare.22.4.593

  5. Wroblewski, M

    • Detection of autonomic sympathetic dysfunction in diabetic patients. A study using laser Doppler imaging. Diabetes Care April 1999 22:593-597; doi:10.2337/diacare.22.4.593

X

  1. Xiang, K

    • RAGE Gly82Ser polymorphism in diabetic microangiopathy. Diabetes Care April 1999 22:646; doi:10.2337/diacare.22.4.646

Y

  1. Yamaguchi, Y

    • Insulitis in an autoimmune-mediated patient originally classified as having type 2 diabetes. Diabetes Care April 1999 22:541-542; doi:10.2337/diacare.22.4.541

  2. Yoo, W H

    • Marked weight loss in a type 2 diabetic patient treated with acarbose. Diabetes Care April 1999 22:645-646; doi:10.2337/diacare.22.4.645

  3. Young-Hyman, D

    • Biopsychobehavioral model of risk of severe hypoglycemia. Self-management behaviors. Diabetes Care April 1999 22:580-584; doi:10.2337/diacare.22.4.580

  4. Yue, D K

    • Possible sources of discrepancies in the use of the Semmes-Weinstein monofilament. Impact on prevalence of insensate foot and workload requirements. Diabetes Care April 1999 22:598-602; doi:10.2337/diacare.22.4.598

Z

  1. Zijlstra, F

    • Primary angioplasty compared with thrombolysis in acute myocardial infarction in diabetic patients. Diabetes Care April 1999 22:647-649; doi:10.2337/diacare.22.4.647a

  2. Zinman, B

    • Effectiveness of human ultralente versus NPH insulin in providing basal insulin replacement for an insulin lispro multiple daily injection regimen. A double-blind randomized prospective trial. The Canadian Lispro Study Group. Diabetes Care April 1999 22:603-608; doi:10.2337/diacare.22.4.603

Current Issue

  1. February 2012, 35 (2)
  1. Current Issue
  1. Alert me to new issues of Diabetes Care
Advertisement